Evidence map›Paper›PMID 25030633›Full record

ArticleBMJ (Clinical research ed.)2014

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Benjamin Kasenda, Stefan Schandelmaier, Xin Sun, Erik von Elm, John You, Anette Blümle, Yuki Tomonaga, Ramon Saccilotto, Alain Amstutz, Theresa Bengough and 30 more

Erratum issuedAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Kasenda, Benjamin [added]; Schandelmaier, Stefan [added]; Sun, Xin [added]; von Elm, Erik [added]; You, John [added]; Blümle, Anette [added]; Tomonaga, Yuki (8) Saccilotto, Ramon (9) Amstutz, Alain [added]; Bengough, Theresa [added]; etc.
5 · Who and what money

Authors and funding

40 authors.

Benjamin Kasenda
Stefan Schandelmaier
Xin Sun
Erik von Elm
John You
Anette Blümle
Yuki Tomonaga
Ramon Saccilotto
Alain Amstutz
Theresa Bengough
Joerg J Meerpohl
Mihaela Stegert
Kelechi K Olu
Kari A O Tikkinen
Ignacio Neumann
Alonso Carrasco-Labra
Markus Faulhaber
Sohail M Mulla
Dominik Mertz
Elie A Akl
Dirk Bassler
Jason W Busse
Ignacio Ferreira-González
Francois Lamontagne
Alain Nordmann
Viktoria Gloy
Heike Raatz
Lorenzo Moja
Rachel Rosenthal
Shanil Ebrahim
Per O Vandvik
Bradley C Johnston
Martin A Walter
Bernard Burnand
Matthias Schwenkglenks
Lars G Hemkens
Heiner C Bucher
Gordon H Guyatt
Matthias Briel
DISCO Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the planning of subgroup analyses in protocols of randomised controlled trials and the agreement with corresponding full journal publications.

designCohort of protocols of randomised controlled trial and subsequent full journal publications.

settingSix research ethics committees in Switzerland, Germany, and Canada. DATA SOURCES: 894 protocols of randomised controlled trial involving patients approved by participating research ethics committees between 2000 and 2003 and 515 subsequent full journal publications.

resultsOf 894 protocols of randomised controlled trials, 252 (28.2%) included one or more planned subgroup analyses. Of those, 17 (6.7%) provided a clear hypothesis for at least one subgroup analysis, 10 (4.0%) anticipated the direction of a subgroup effect, and 87 (34.5%) planned a statistical test for interaction. Industry sponsored trials more often planned subgroup analyses compared with investigator sponsored trials (195/551 (35.4%) v 57/343 (16.6%), P<0.001). Of 515 identified journal publications, 246 (47.8%) reported at least one subgroup analysis. In 81 (32.9%) of the 246 publications reporting subgroup analyses, authors stated that subgroup analyses were prespecified, but this was not supported by 28 (34.6%) corresponding protocols. In 86 publications, authors claimed a subgroup effect, but only 36 (41.9%) corresponding protocols reported a planned subgroup analysis.

conclusionsSubgroup analyses are insufficiently described in the protocols of randomised controlled trials submitted to research ethics committees, and investigators rarely specify the anticipated direction of subgroup effects. More than one third of statements in publications of randomised controlled trials about subgroup prespecification had no documentation in the corresponding protocols. Definitive judgments regarding credibility of claimed subgroup effects are not possible without access to protocols and analysis plans of randomised controlled trials.

Indexed as

Clinical ProtocolsResearch DesignCanadaCohort StudiesData CollectionGermanyHumansPublishingRandomized Controlled Trials as TopicSwitzerland

Identifiers

PMID25030633
PMCPMC4100616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.